February 10, 2026
ILiAD Biotechnologies
ILiAD is a clinical-stage biotechnology company...
- Round
- Series D
- Amount raised
- $115M
- Lead investor
- Knott Partners
- Industry
- Biotechnology, Clinical Trials
- Headquarters
- New York, New York
- Employees
- 11-50
- Website
- iliadbio.com
- —
Other investors
- National Institutes